AAAAAA
Results: 226-250/860
Authors:
Schuh, JCL
Morrissey, PJ
Citation: Jcl. Schuh et Pj. Morrissey, Development of a recombinant growth factor and fusion protein: Lessons from GM-CSF, TOX PATHOL, 27(1), 1999, pp. 72-77
Authors:
Ryan, AM
Eppler, DB
Hagler, KE
Bruner, RH
Thomford, PJ
Hall, RL
Shopp, GM
O'Neill, CA
Citation: Am. Ryan et al., Preclinical safety evaluation of rhuMAbVEGF, an antiangiogenic humanized monoclonal antibody, TOX PATHOL, 27(1), 1999, pp. 78-86
Authors:
Haggerty, HG
Warner, WA
Comereski, CR
Peden, WM
Mezza, LE
Damle, BD
Siegall, CB
Davidson, TJ
Citation: Hg. Haggerty et al., BR96 sFv-PE40 immunotoxin: Nonclinical safety assessment, TOX PATHOL, 27(1), 1999, pp. 87-94
Authors:
Henry, SP
Templin, MV
Gillett, N
Rojko, J
Levin, AA
Citation: Sp. Henry et al., Correlation of toxicity and pharmacokinetic properties of a phosphorothioate oligonucleotide designed to inhibit ICAM-1, TOX PATHOL, 27(1), 1999, pp. 95-100
Authors:
Nemecek, GM
Dayan, AD
Citation: Gm. Nemecek et Ad. Dayan, Safety evaluation of human living skin equivalents, TOX PATHOL, 27(1), 1999, pp. 101-103
Authors:
Alden, CL
Sagartz, JE
Smith, PF
Wilson, AG
Bunch, RT
Morris, DL
Citation: Cl. Alden et al., The pathologist and toxicologist in pharmaceutical product discovery, TOX PATHOL, 27(1), 1999, pp. 104-106
Authors:
Rodi, CP
Bunch, RT
Curtiss, SW
Kier, LD
Cabonce, MA
Davila, JC
Mitchell, MD
Alden, CL
Morris, DL
Citation: Cp. Rodi et al., Revolution through genomics in investigative and discovery toxicology, TOX PATHOL, 27(1), 1999, pp. 107-110
Authors:
Rudmann, DG
Durham, SK
Citation: Dg. Rudmann et Sk. Durham, Utilization of genetically altered animals in the pharmaceutical industry, TOX PATHOL, 27(1), 1999, pp. 111-114
Authors:
Schuh, JCL
Harrington, KA
Citation: Jcl. Schuh et Ka. Harrington, Mechanisms of disease and injury: Utilization of mutants, monoclonals, andmolecular methods, TOX PATHOL, 27(1), 1999, pp. 115-120
Authors:
Arp, LH
Citation: Lh. Arp, Tumor models: Assessing toxicity in efficacy studies, TOX PATHOL, 27(1), 1999, pp. 121-122
Authors:
Leach, MW
Davidson, NJ
Fort, MM
Powrie, F
Rennick, DM
Citation: Mw. Leach et al., The role of IL-10 in inflammatory bowel disease: "Of mice and men", TOX PATHOL, 27(1), 1999, pp. 123-133
Authors:
Bendele, A
McComb, J
Gould, T
McAbee, T
Sennello, G
Chlipala, E
Guy, M
Citation: A. Bendele et al., Animal models of arthritis: Relevance to human disease, TOX PATHOL, 27(1), 1999, pp. 134-142
Authors:
Hartke, JR
Citation: Jr. Hartke, Preclinical development of agents for the treatment of osteoporosis, TOX PATHOL, 27(1), 1999, pp. 143-147
Authors:
DEANGELO AB
GEORGE MH
KILBURN SR
MOORE TM
WOLF DC
Citation: Ab. Deangelo et al., CARCINOGENICITY OF POTASSIUM BROMATE ADMINISTERED IN THE DRINKING-WATER TO MALE B6C3F(1) MICE AND F344 N RATS/, Toxicologic pathology, 26(5), 1998, pp. 587-594
Authors:
KIMURA T
DOI K
Citation: T. Kimura et K. Doi, EFFECTS OF ALL-TRANS-RETINOIC ACID ON THE DORSAL SKIN OF HAIRLESS DOGS, Toxicologic pathology, 26(5), 1998, pp. 595-601
Authors:
HAILEY JR
HASEMAN JK
BUCHER JR
RADOVSKY AE
MALARKEY DE
MILLER RT
NYSKA A
MARONPOT RR
Citation: Jr. Hailey et al., IMPACT OF HELICOBACTER-HEPATICUS INFECTION IN B6C3F(1) MICE FROM 12 NATIONAL TOXICOLOGY PROGRAM 2-YEAR CARCINOGENESIS STUDIES, Toxicologic pathology, 26(5), 1998, pp. 602-611
Authors:
KHAN KNM
VENTURINI CM
BUNCH RT
BRASSARD JA
KOKI AT
MORRIS DL
TRUMP BF
MAZIASZ TJ
ALDEN CL
Citation: Knm. Khan et al., INTERSPECIES DIFFERENCES IN RENAL LOCALIZATION OF CYCLOOXYGENASE ISOFORMS - IMPLICATIONS IN NONSTEROIDAL ANTIINFLAMMATORY DRUG-RELATED NEPHROTOXICITY, Toxicologic pathology, 26(5), 1998, pp. 612-620
Authors:
LEE VM
CAMERON RG
ARCHER MC
Citation: Vm. Lee et al., ZONAL LOCATION OF COMPENSATORY HEPATOCYTE PROLIFERATION FOLLOWING CHEMICALLY-INDUCED HEPATOTOXICITY IN RATS AND HUMANS, Toxicologic pathology, 26(5), 1998, pp. 621-627
Authors:
GIOVANETTI A
ROSSI L
MANCUSO H
LOMBARDI CC
MARASCO MR
MANNA F
ALTAVISTA P
MASSA EM
Citation: A. Giovanetti et al., ANALYSIS OF LUNG DAMAGE-INDUCED BY TRICHLOROETHYLENE INHALATION IN MICE FED DIETS WITH LOW, NORMAL, AND HIGH COPPER CONTENT, Toxicologic pathology, 26(5), 1998, pp. 628-635
Authors:
WIRNITZER U
TOPFER R
ROSENBRUCH M
Citation: U. Wirnitzer et al., ALTERED P53 EXPRESSION IN EARLY STAGES OF CHEMICALLY-INDUCED RODENT HEPATOCARCINOGENESIS, Toxicologic pathology, 26(5), 1998, pp. 636-645
Authors:
HONG HHL
DEVEREUX TR
ROYCROFT JH
BOORMAN GA
SILLS RC
Citation: Hhl. Hong et al., FREQUENCY OF RAS MUTATIONS IN LIVER NEOPLASMS FROM B6C3F(1) MICE EXPOSED TO TETRAFLUOROETHYLENE FOR 2 YEARS, Toxicologic pathology, 26(5), 1998, pp. 646-650
Authors:
BREIDER MA
ULLOA HM
PEGG DG
GOUGH AW
Citation: Ma. Breider et al., NITRO-IMIDAZOLE RADIOSENSITIZER-INDUCED TOXICITY IN CYNOMOLGUS MONKEYS, Toxicologic pathology, 26(5), 1998, pp. 651-656
Authors:
WILSON CL
SAFE S
Citation: Cl. Wilson et S. Safe, MECHANISMS OF LIGAND-INDUCED ARYL-HYDROCARBON RECEPTOR-MEDIATED BIOCHEMICAL AND TOXIC RESPONSES, Toxicologic pathology, 26(5), 1998, pp. 657-671
Authors:
WILKER C
Citation: C. Wilker, ARE THERE REDEEMING QUALITIES IN ONE OF NATURES TOXIC ORPHAN RECEPTORS, Toxicologic pathology, 26(5), 1998, pp. 672-673
Authors:
SHINOZUKA J
SUZUKI M
NOGUCHI N
SUGIMOTO T
UETSUKA K
NAKAYAMA H
DOI K
Citation: J. Shinozuka et al., T-2 TOXIN-INDUCED APOPTOSIS IN HEMATOPOIETIC TISSUES OF MICE, Toxicologic pathology, 26(5), 1998, pp. 674-681